| scholarly article | Q13442814 |
| P50 | author | Carolyn Gotay | Q85655863 |
| P2093 | author name string | M Sprangers | |
| A Bottomley | |||
| C Coens | |||
| F Efficace | |||
| D Osoba | |||
| P433 | issue | 4 | |
| P921 | main subject | decision making | Q1331926 |
| quality of life | Q13100823 | ||
| P304 | page(s) | 775-781 | |
| P577 | publication date | 2007-01-27 | |
| P1433 | published in | Annals of Oncology | Q326122 |
| P1476 | title | Has the quality of health-related quality of life reporting in cancer clinical trials improved over time? Towards bridging the gap with clinical decision making | |
| P478 | volume | 18 |
| Q37729195 | Added value of health-related quality of life measurement in cancer clinical trials: the experience of the NCIC CTG. |
| Q24193138 | Androgens for the anaemia of chronic kidney disease in adults |
| Q24242990 | Androgens for the anaemia of chronic kidney disease in adults |
| Q37392987 | Baseline quality of life factors predict long term survival after elective resection for colorectal cancer |
| Q37864715 | Cautionary tales in the clinical interpretation of trials assessing therapy-induced changes in health status. |
| Q24243598 | Chinese herbal medicine alone or combined with vitamins for gastric precancerous lesions |
| Q24186392 | Chinese herbal medicine for oesophageal cancer |
| Q24240294 | Chinese herbal medicines for esophageal cancer |
| Q45973699 | Disregarding clinical trial-based patient-reported outcomes is unwarranted: Five advances to substantiate the scientific stringency of quality-of-life measurement. |
| Q30467905 | Effects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials |
| Q92922997 | Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review |
| Q47555206 | Health-related quality of life among long-term (≥5 years) prostate cancer survivors by primary intervention: a systematic review |
| Q37810109 | Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes |
| Q38891401 | Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials |
| Q35111780 | Health-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials |
| Q38105945 | Health-related quality of life in patients with brain tumors: limitations and additional outcome measures |
| Q37038467 | Health-related quality of life with adjuvant docetaxel- and trastuzumab-based regimens in patients with node-positive and high-risk node-negative, HER2-positive early breast cancer: results from the BCIRG 006 Study |
| Q37639326 | Health-related quality-of-life assessment in GI cancer randomized trials: improving the impact on clinical practice |
| Q41701973 | Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy-a European Organization f |
| Q30668504 | How should we manage information needs, family anxiety, depression, and breathlessness for those affected by advanced disease: development of a Clinical Decision Support Tool using a Delphi design |
| Q24240566 | Immunosuppressants for the prophylaxis of corneal graft rejection after penetrating keratoplasty |
| Q35771173 | Impact of Radiotherapy When Added to Androgen-Deprivation Therapy for Locally Advanced Prostate Cancer: Long-Term Quality-of-Life Outcomes From the NCIC CTG PR3/MRC PR07 Randomized Trial |
| Q37067944 | Improving patient-centered medical-surgical nursing practice with quality-of-life assessment |
| Q64883385 | Measurement of quality of life in second-line patients with advanced NSCLC without targetable mutations: a review. |
| Q24243668 | Medicinal herbs for esophageal cancer |
| Q44669659 | Methodological issues in designing and reporting health-related quality of life in cancer clinical trials: the challenge of brain cancer studies |
| Q38103621 | Patient-reported outcomes in bariatric surgery: a systematic review of standards of reporting. |
| Q37812571 | Patterns of reporting health-related quality of life outcomes in randomized clinical trials: implications for clinicians and quality of life researchers |
| Q38674157 | Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results. |
| Q48061245 | Poor patient-reported outcomes reporting according to CONSORT guidelines in randomized clinical trials evaluating systemic cancer therapy. |
| Q35801547 | Quality of Life in CAM and Non-CAM Users among Breast Cancer Patients during Chemotherapy in Malaysia |
| Q38893045 | Quality of Life in Community-Dwelling Chinese American Patients with Cancer Pain |
| Q37008863 | Quality of life and adjuvant systemic therapy for early-stage breast cancer |
| Q47908896 | Quality of life questionnaires in otorhinolaryngology: a systematic overview |
| Q37615519 | Quality of life research: types of publication output over time for cancer patients, a systematic review |
| Q36584771 | Quality of patient-reported outcome reporting across cancer randomized controlled trials according to the CONSORT patient-reported outcome extension: A pooled analysis of 557 trials |
| Q37306764 | Quality-of-life assessment in phase III clinical trials of gemcitabine in non-small-cell lung cancer |
| Q37049160 | Quality-of-life issues in the management of epithelial ovarian cancer |
| Q30671538 | Reporting of health-related quality of life (HRQOL) data in oncology trials: a comparison of the European Organization for Research and Treatment of Cancer Quality of Life (EORTC QLQ-C30) and the Functional Assessment of Cancer Therapy-General (FACT |
| Q48145007 | Reporting of health-related quality of life in randomized controlled trials involving palliative systemic therapy for esophagogastric cancer: a systematic review. |
| Q37614291 | Reporting on quality of life in randomised controlled trials in gastrointestinal surgery |
| Q34293847 | Scientific imperatives, clinical implications, and theoretical underpinnings for the investigation of the relationship between genetic variables and patient-reported quality-of-life outcomes |
| Q38053978 | Systematic review reveals limitations of studies evaluating health-related quality of life after potentially curative treatment for esophageal cancer |
| Q31034367 | The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative |
| Q42862858 | The CONSORT Patient-Reported Outcome (PRO) extension: implications for clinical trials and practice |
| Q48038841 | The longitudinal relationship between quality of life and survival in advanced stage cancer. |
| Q53173828 | The prognostic effects of performance status and quality of life scores on progression-free survival and overall survival in advanced ovarian cancer. |
| Q36594133 | Validation of the EORTC QLQ-GINET21 questionnaire for assessing quality of life of patients with gastrointestinal neuroendocrine tumours |
Search more.